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Abstract 
Background: Medulloblastoma is one of the most common types of pediatric brain tumor characterized by the 
subpopulation of cells that exhibit high invasive potential and radioresistant properties. In addition, dysregulated 
function and signaling by Eph family of receptors have been shown to impart pro-tumorigenic characteristics in this 
brain malignancy. In the current study, we investigated whether EphB2 knockdown in combination with radiation can 
alter invasiveness and decrease medulloblastoma tumor growth or viability in vitro.
Methods: The expression of EphB2 receptor was analyzed by immunohistochemistry and Western blotting. Microar-
ray analysis and mRNA analysis was performed on medulloblastoma patient datasets and compared to the normal 
cerebellum. The radiosensitization effect following EphB2 knockdown was determined by clonogenic assay in human 
medulloblastoma cells. Effects of EphB2-siRNA in absence or presence of radiation on cell cycle distribution, cell 
viability, and invasion were analyzed by flow cytometry, MTT assay, trypan blue exclusion assay, xcelligence system, 
and Western blotting.
Results: We observed that EphB2 is expressed in both medulloblastoma cell lines and patient samples and its down-
regulation sensitized these cells to radiation as evident by decreased clonogenic survival fractions. EphB2 expression 
was also high across different medulloblastoma subgroups compared to normal cerebellum. The radiosensitization 
effect observed following EphB2 knockdown was in part mediated by enhanced G2/M cell cycle arrest. We also found 
that the combined approach of EphB2 knockdown and radiation exposure significantly reduced overall cell viability 
in medulloblastoma cells compared to control groups. Similar results were obtained in the xcelligence-based invasion 
assay. Western blot analysis also demonstrated changes in the protein expression of cell proliferation, cell survival, and 
invasion molecules in the combination group versus others.
Conclusions: Overall, our findings indicate that specific targeting of EphB2 receptor in combination with radiation 
may serve as an effective therapeutic strategy in medulloblastoma. Future studies are warranted to test the efficacy of 
this approach in in vivo preclinical models.
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Background
Medulloblastoma constitutes one of the most aggressive and 
commonly diagnosed brain malignancies in children [1]. It 
arises from granule neuronal precursor cells in the cerebel-
lum or from neural stem cells of the rhombic lip [1]. The 
standard of care treatment for medulloblastoma is combi-
nation of surgical resection, chemotherapy, and radiation 
therapy [2] but tumor recurrence remains a major problem.
One of the hallmarks of medulloblastoma is rapid and 
extensive central nervous system (CNS) dissemination 
along leptomeningeal surfaces because of the presence of 
migratory and invasive cell populations [3]. To date, con-
certed research efforts have been directed in targeting 
these invasive and recurrent subpopulations in a tumor 
cell mass. However, the outcomes remain dismal. This 
can be attributed to the dysregulated function of some 
of the tyrosine kinase receptors that impart radioresist-
ant properties and invasive potential to these tumors. For 
example, Morrison et  al. [4], reported that certain Eph 
receptor tyrosine kinases and ligands were aberrantly 
regulated in the migrating medulloblastoma cells versus 
core tumor cells. These migrating cells were character-
ized by upregulation of EphB2 as shown by qPCR analy-
sis in DAOY medulloblastoma cells [4]. EphB2 has also 
been shown to play a critical role in medulloblastoma, 
ependymoma, and glioblastoma (GBM) by other research 
groups [5–7]. For example, Sikemma et  al. [5], demon-
strated increased invasion in EphB2-expressing medul-
loblastoma cell lines following ligand stimulation. This 
effect was completely blocked upon shRNA-mediated 
knockdown of EphB2 [5]. Another group showed that 
EphB2 overexpression enhanced neurosphere cell migra-
tion and invasion and its targeted inhibition resulted in 
decreased invasion/migration in the GBM model [6].
Tumor cell migration is known to be facilitated by 
components such as fibronectin and collagen predomi-
nantly present in leptomeningeal extracellular matrix 
[8]. In addition to intrinsic promoters of cell migration 
such as fibronectin and collagen [8], treatment-related 
factors have been reported to increase tumor cell motil-
ity. Photon irradiation (IR), a standard of care in medul-
loblastoma treatment, has been suggested to enhance 
medulloblastoma cell invasion, and preclinical studies 
have demonstrated increased tumor cell invasiveness 
through upregulation of urokinase plasminogen activator 
receptor (uPAR) signaling [9]. Conversely, other groups 
have shown a decrease in migration and invasion follow-
ing various dosing of photons and carbon ion irradiation 
[10], suggesting that additional studies are needed.
Therefore, in this study, we sought to address whether 
the combination of EphB2 knockdown with radiation 
would negate any pro-invasive effects radiation may 
have on medulloblastoma cells. In contrast to some 
observations in medulloblastoma cells [9, 11] and in non-
medulloblastoma tumor cells [12], our data show that ion-
izing radiation did not promote tumor cell invasion but 
instead significantly decreased invasion, particularly in 
combination with EphB2 knockdown, which is consistent 
with other reports [10]. In addition, we found that knock-
down of EphB2, combined with radiation, decreased cell 
viability and clonogenic survival, in part through the inhi-
bition of cell cycle progression. This is the first study to 
show the impact of EphB2 inhibition in combination with 
radiation in medulloblastoma cells and provides a rational 
basis for targeted inhibition of the EphB2 receptor as a 
potential radiosensitization strategy in medulloblastoma.
Methods
Medulloblastoma patient samples and cell lines
The cohort of medulloblastoma patient samples (n = 33) 
was obtained from Children’s Hospital Colorado and in 
compliance with local and federal human research pro-
tection guidelines and Institutional Review Board regu-
lations (COM-IRB 95-500). Out of 33 patients analyzed, 
there were 8 females and 25 males (Additional file  1: 
Table S1). Additional information on the age distribution 
is included in Additional file 1: Table S1. Normal cerebel-
lum samples (n = 5) were obtained from non-malignant 
brain autopsies at the Children’s Hospital Colorado fol-
lowing Institutional Review Board guidelines. The human 
medulloblastoma cell lines DAOY and UW228 were 
obtained from the American Type Culture Collection 
(ATCC, Rockville, MD, USA). These cell lines were main-
tained in Dulbecco’s Modified Eagle’s Medium (DMEM), 
supplemented with 10% fetal bovine serum, and primocin 
(Invivogen, San Diego, CA, USA) at 37 °C and 5% CO2.
RNA extraction and microarray data analysis
Total RNA was extracted from all surgical samples, 
amplified, labeled, and hybridized to Affymetrix plus 
2 microarray chips (Affymetrix, Santa Clara, CA, USA) 
according to manufacturer’s instructions. Data analysis 
was performed in the R programming language using 
open-source available through Bioconductor (http://
www.bioconductor.org) as described earlier [13].
Human EphB2 mRNA expression analysis
EPHB2 expression was analyzed by using the R2 plat-
form (http://r2.amc.nl). Specifically, the following data-
sets were utilized for analysis: Medulloblastoma Kool 
(GSE10327) [14] and Medulloblastoma Gilbertson 
(GSE37418) [15]. The subgroups in the Kool’s dataset 
are labeled based on the published literature [16, 17]. For 
normal expression, the Normal Cerebellum Roth data-
set (GSE3526) was utilized. One-way analysis of variance 
was performed to compare EPHB2 expression across 
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medulloblastoma subgroups with normal cerebellum 
expression.
Immunohistochemistry
Normal human cerebellum and medulloblastoma patient 
sample was used to analyze the expression of EphB2 
receptor by immunohistochemistry. Briefly, formalin-
fixed and paraffin embedded tumor sections were depar-
affinized and hydrated followed by antigen retrieval. 
Endogenous peroxidase activity was blocked by incubat-
ing the samples in 3% H2O2 in PBS for 30  min at room 
temperature. Sections were blocked in 2% milk followed 
by overnight incubation with anti-EphB2 antibody (5 μg/
mL) at 4 °C. Anti-EphB2 antibody [18] was a kind gift by 
Dr. Elena B. Pasquale (Sanford Burnham Prebys Medi-
cal Discovery Institute, San Diego, CA, USA). Following 
washing in TBS, samples were incubated with biotinylated 
anti-rabbit secondary antibody for 1 h at room tempera-
ture, followed by staining with DAB reagent. Sections 
were counterstained with hematoxylin, and images were 
captured on a 20× objective using Nikon microscope.
siRNA transfection
For transfection experiments, two different EphB2 tar-
geting siRNAs were used. DAOY and UW228 cells 
were transfected in serum-free DMEM using TransIT-
TKO Transfection Reagent (Mirus, Madison, WI, USA), 
according to the manufacturer’s instructions. Short inter-
fering RNAs (siRNA) specific for human EphB2 and the 
non-specific control siRNA (NS-siRNA) were obtained 
from Invitrogen (Carlsbad, CA, USA). For the functional 
and mechanistic experiments reported in this study, cells 
were transfected using 10  μL TransIT-TKO for a final 
working concentration of 25 nM siRNA. The transfection 
complex was added to the cells and 20  h post-transfec-
tion, the medium was replaced with fresh serum-contain-
ing and antibiotic-containing growth medium. Cells were 
analyzed at optimal time-points by different assays.
Irradiation
Cells were irradiated with indicated radiation doses using 
a RS-2000 (Rad Source Technologies, Inc) X-ray irradia-
tor, a 160 KVp source, at 25 mAmp, and at a dose rate of 
1.24 Gy/min.
Whole cell lysate preparation and immunoblotting
Medulloblastoma cells transfected with EphB2-siRNA 
or control NS-siRNA in the absence or the presence of 
radiation were harvested at different time-points. Cells 
were homogenized in RIPA lysis buffer (Millipore, Bill-
erica, MA, USA), containing protease inhibitor cocktail 
(Thermo Fisher Scientific Inc., IL, USA) and phosphatase 
inhibitor (Sigma, MO, USA) on ice for 30  min. The 
homogenate was centrifuged at 4  °C at 13,000  rpm for 
20  min, and lysates were collected. Protein concentra-
tion was determined using the BCA Protein Assay kit 
(Thermo Fisher Scientific Inc., IL, USA). Lysates (20–
30  μg) were loaded onto 10–12% SDS-PAGE gels. Elec-
trophoresis, blocking, probing, and detection of proteins 
were conducted as described earlier [19]. Membranes 
were probed overnight at 4 °C with respective antibodies. 
All primary antibodies (anti-PCNA, anti-Bcl-XL/S, anti-
vimentin, anti-cyclinB1, and anti-β-actin) were obtained 
from Cell Signaling Technology (Danvers, MA, USA). 
Horseradish peroxidase (HRP)–conjugated secondary 
antibodies were obtained from Sigma (St. Louis, MO, 
USA).
Clonogenic survival assay
Clonogenic survival fractions were determined following 
increasing doses of X-ray ionizing radiation. Cells in cul-
ture were exposed to ionizing radiation in 25 cm3 flasks. 
Clonogenic cell survival was analyzed as described [19]. 
Colonies comprising of at least 50 cells were counted 
9–14  days post radiation treatment. After counting col-
onies, plating efficiency (PE) and survival fraction (SF) 
were determined using the formulas below:
Survival fraction following ionizing radiation in NS-
siRNA or EphB2-siRNA transfected cells was normalized 
taking into consideration plating efficiency in that par-
ticular group at 0 Gy. Each experiment was replicated at 
least three times.
Cell cycle analysis
DAOY cells were seeded at a density of 75,000 cells per 
well in six-well plates in DMEM medium containing 
10% FBS and primocin. Following overnight incuba-
tion, cells were transfected using 25 nM EphB2-siRNA 
or control NS-siRNA in serum-free, antibiotic-free 
growth medium. At 24 h after transfection, the medium 
was exchanged with growth medium containing pri-
mocin and cells were irradiated using X-ray irradiator. 
At 72 h post-radiation, cells were harvested, washed in 
ice-cold PBS, fixed overnight in 70% ethanol, followed 
by staining with propidium iodide. Cell cycle distribu-
tion was analyzed at the indicated time-point by flow 
cytometer.
MTT assay
DAOY and UW228 cells were seeded at a density of 
150,000 cells per well in six-well plates and maintained 
PE = Number of colonies formed/Number of cells seeded
SF = Number of colonies formed after ionizing radiation/
Number of cells seeded × PE
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in DMEM supplemented with 10% FBS, primocin for 
24 h prior to transfection with siRNA. Cells were trans-
fected using 25 nM EphB2-siRNA or control NS-siRNA 
in serum-free, antibiotic-free DMEM. At 24  h after 
transfection, medium was exchanged for 10% DMEM 
containing primocin and cells were replated at a den-
sity of 3000 cells/well in 96-well plates. After overnight 
incubation, cells were exposed to 8 Gy dose of radiation 
and analyzed 144 h later following addition of the MTT 
[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide] reagent (Sigma, St. Louis, MO, USA). Optical 
density was measured on a microplate reader at a wave-
length of 590 nm.
Trypan blue dye exclusion
DAOY and UW228 cells were seeded at a density of 150,000 
cells per well in six-well plates and maintained in DMEM 
containing 10% FBS and primocin. Cells were transfected 
as indicated above and replated at a density of 30,000 cells/
well in a six-well plate. Approximately 24  h post-plating, 
cells were exposed to 8  Gy dose of radiation. After 120–
144 h post-radiation, cells were collected by trypsinization. 
To each 10 μL aliquot of cells, 10 μL of trypan blue dye was 
added. Cell counting was performed using the T-20 auto-
mated cell counter (Bio-Rad, Hercules, CA, USA).
Invasion assay
The xCELLigence RTCA DP Analyzer (Roche, CA) was 
used to determine the effect of EphB2 knockdown in 
absence and presence of radiation on invasion in a CIM-
16 plate (ACEA Biosciences, San Diego, CA, USA). The 
CIM-16 plate is a modified Boyden chamber in which 
the porous membrane separating the double-chambered 
well is coated with gold microelectrodes. In this system, 
cells invading through the upper chamber into the lower 
chamber adhere to these microelectrodes, increasing the 
electrical impedance across this membrane. Electrical 
impedance is measured as a “cell index,” which directly 
correlates to the number of cells that have invaded into 
the lower chamber and adhered to the underside of the 
membrane. Background measurement was taken by 
adding cell-free, serum-free DMEM to the upper and 
lower chambers of each well. The plate was incubated 
at 37  °C for 1  h prior to measuring background electri-
cal impedance for each well. At 20 h post-radiation, cells 
were starved for 4  h in serum-free, and antibiotic-free 
DMEM, prior to collection by trypsinization. Cells were 
resuspended in serum-free DMEM with primocin and 
seeded in the upper chamber (coated with 1:40 dilution 
of matrigel) at a density of 50,000 cells per well. Invasion 
was monitored for 35 h. Delta cell index values were cal-
culated by subtracting cell index values in the absence of 
a serum gradient from cell index values in the presence 
of a serum gradient. Cell index values between different 
treatment groups were determined at 3 h-intervals after 
the start of the experiment.
Statistical analysis
All the experiments were performed in duplicate or 
triplicate and repeated two to three times. Quantitative 
analyses were performed using Student’s t test or one way 
ANOVA by GraphPad Prism software. A p value of <0.05 
was considered significant.
Results
Medulloblastoma patient samples express high levels 
of EphB2 receptor
Morrison et  al. [4], reported significant upregulation 
in transcript levels of the EphB2 receptor in migrating 
medulloblastoma cells. Based on recent studies, medul-
loblastoma can be categorized into four distinct molecu-
lar subtypes: Wnt, Sonic Hedgehog (SHH), Group 3, and 
Group 4 [16, 17]. We analyzed transcriptomic data per-
formed on a cohort of medulloblastoma patients obtained 
from Children’s Hospital Colorado and found that EphB2 
is significantly overexpressed in these samples compared 
to the non-malignant brain samples (Fig.  1a). We also 
performed mRNA analysis on the two different datasets: 
Medulloblastoma Kool (GSE10327) [14] and Medulloblas-
toma Gilbertson (GSE37418) [15]. Although variability 
can be seen across the different datasets, similar trends 
were observed with all the four medulloblastoma subtypes 
showing elevated expression of EphB2 compared to the 
normal cerebellum (Fig. 1b, c). We next validated these data 
by analyzing the expression of EphB2 receptor in medullo-
blastoma patient samples by immunohistochemistry. Nor-
mal cerebellum was used as a negative control. As shown in 
Fig. 1d, higher EphB2 levels are present in medulloblastoma 
patient samples as compared to the normal cerebellum.
EphB2 receptor is efficiently knocked down using targeted 
siRNA approach in medulloblastoma cells
We validated the expression of EphB2 in two different 
human medulloblastoma cell lines DAOY and UW228. 
The DAOY cell line is derived from a 4-year old male 
patient and the UW228 cell line is derived from a 9-year 
old female patient [20]. The EphB2 receptor is expressed 
in both DAOY and UW228 cells (Fig. 1e). To investigate 
the functional role of EphB2 in our in  vitro model sys-
tem, we transiently transfected medulloblastoma cells 
with either an EphB2-siRNA or a control NS-siRNA and 
analyzed the knockdown efficiency at protein level. Our 
Western blot analyses show a reduction in EphB2 levels 
in the cells transfected with EphB2-specific siRNA com-
pared to control NS-siRNA at 72  h post-transfection 
(Fig. 1e).
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EphB2 receptor knockdown sensitizes medulloblastoma 
cells to ionizing radiation
Clonogenic survival assays were performed to determine 
whether knockdown of EphB2 receptor can enhance radi-
osensitization in medulloblastoma cells. EphB2-siRNA 
or NS-siRNA transfected cells were subjected to increas-
ing doses (0, 2, 4, 6, and 8 Gy) of ionizing radiation. After 
9–14 days of radiation treatment, we analyzed the clono-
genic survival fractions in both experimental and control 
groups. Our data demonstrate that following EphB2 knock-
down, both DAOY and UW228 cells became more sensi-
tive to ionizing radiation (Fig. 2a, b). Analysis of the survival 
fractions in DAOY cells show that SF6 (survival fraction at 
6 Gy dose of ionizing radiation) values were decreased from 
0.09 in the NS-siRNA control group to 0.05 in the EphB2 
knockdown group (Fig. 2a). In UW228 cells, the SF6 values 
were reduced from 0.06 in NS-siRNA transfected group to 
0.04 in the EphB2 siRNA transfected group (Fig. 2b).
Fig. 1 EphB2 is expressed in both medulloblastoma patient samples from different medulloblastoma subtypes and cell lines. a Transcriptomic data 
analysis show that EphB2 receptor is overexpressed in four distinct medulloblastoma subtypes compared to normal counterparts. Similar trend 
was evident with the mRNA analysis performed on EPHB2 expression by using the R2 platform (http://r2.amc.nl). The Medulloblastoma Gilbertson 
(GSE37418) dataset (b) and Kool (GSE10327) dataset (c) were used for the analysis [15]. For normal expression the Normal Cerebellum Roth dataset 
(GSE3526) was utilized. The subgroups in the Kool’s dataset are labeled based on the published literature [16, 17]. One-way analysis of variance was 
performed to compare EPHB2 expression across medulloblastoma subgroups with normal cerebellum expression. d IHC analysis show that EphB2 
is expressed at high levels in medulloblastoma patient samples compared to the normal cerebellum. e EphB2 expression is decreased following 
transfection with EphB2-specific siRNA alone and in the presence of 8 Gy dose of radiation compared to control non-specific siRNA (NS-siRNA) at 
72 h post-XRT
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EphB2 receptor knockdown followed by radiation 
enhances cell cycle distribution in G2/M phase 
in medulloblastoma cells
After observing the EphB2-knockdown mediated radio-
sensitization effects in  vitro, we investigated the underly-
ing mechanism by which knockdown of EphB2 enhanced 
radiosensitivity of medulloblastoma cells. Cell cycle analyses 
were performed by flow cytometry to determine the com-
bined effects of EphB2 knockdown and radiation on the cell 
cycle distribution. The DAOY cells transfected with EphB2-
siRNA and exposed to radiation were predominantly 
arrested in the G2/M phase of cell cycle as depicted by an 
increase in percentage of cells (approx. 67%) in this phase 
compared to other treatment groups (Fig.  3a). Further, 
Fig. 2 EphB2 knockdown radiosensitizes medulloblastoma cells to ionizing radiation. Clonogenic assay show reduction in survival fractions in 
DAOY cells (a) and UW228 cells (b) following transfection with EphB2-targeting siRNA (25 nM) versus control NS-siRNA (25 nM) at increasing doses 
of radiation. Each clonogenic assay was repeated at least three times. Representative survival plots are shown for each cell line. Data shown repre-
sent mean ± standard deviation. Student’s t test was used to compare point-by-point differences between NS-siRNA and EphB2-siRNA transfected 
group.*p < 0.05, **p < 0.005
Fig. 3 EphB2 knockdown combined with ionizing radiation results in G2/M arrest in medulloblastoma cells. a Increased accumulation of DAOY 
cells in G2/M phase of the cell cycle is evident in flow cytometry analyses following combined EphB2 knockdown and ionizing radiation. The cells 
were analyzed at 72 h post-radiation. The experiment was repeated at least two to three times. Representative plot is shown for DAOY cell line. b 
An increase in the expression of CyclinB1 is observed in DAOY cells transfected with EphB2-specific siRNA and exposed to 8 Gy dose of radiation. c 
Densitometric analysis was performed to quantify Cyclin B1 expression across different treatment and control groups
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Western blot analysis confirmed an increase in CyclinB1 
protein levels in the EphB2-siRNA transfected cells followed 
by radiation as compared to either NS-siRNA or EphB2-
siRNA transfected groups (Fig.  3b), indicative of arrest in 
the late G2 or the M phase of the cell cycle. Densitometric 
analysis of CyclinB1 expression is shown in Fig. 3c.
Combined EphB2 receptor knockdown with radiation 
decreases medulloblastoma cell growth and viability
We determined the effect of EphB2 knockdown on cell 
viability by performing both MTT and trypan blue exclu-
sion assays. DAOY and UW228 cells that were knocked 
down for EphB2 receptor did not show any significant 
change compared to control siRNA transfected group 
(Fig. 4a, b). However, when the EphB2-siRNA transfected 
cells were combined with an optimal dose of radiation, 
a significant decrease in cell viability was observed in 
both the medulloblastoma cell lines (Fig.  4a, b). Simi-
lar to MTT results, trypan blue data showed significant 
decrease in total number of cells in the EphB2 knock-
down group followed by radiation exposure compared to 
EphB2 knockdown alone or control NS-siRNA group in 
both DAOY and UW228 cells (Fig. 4c, d). In DAOY cells, 
the relative percent of total number of cells decreased to 
~40% in the combination group compared to ~70–75% in 
the single agent treatments (Fig. 4c). In UW228 cells, the 
relative percent of total number of cells declined to ~20% 
in the combination group compared to ~60–70% in the 
single agent treatments (Fig. 4d).
EphB2 knockdown combined with radiation decreases 
invasion in medulloblastoma cells
We next investigated the effect of EphB2 knockdown fol-
lowed by radiation on medulloblastoma cell invasion 
in an electrical impedance-based assay. In DAOY cells, 
although we did not notice any significant change in inva-
sion in the EphB2-siRNA transfected cells compared to 
the NS-siRNA group, combined EphB2 knockdown and 
Fig. 4 EphB2 knockdown when combined with radiation treatment results in decreased cell viability in medulloblastoma cells. MTT analysis (a, 
b) and Trypan blue analysis (c, d) show significant decrease in cell viability and decrease in relative percent of total number of cells in both DAOY 
and UW228 cells when knocked down for EphB2 receptor and combined with 8 Gy dose of radiation compared to other control and experimental 
groups at 120–144 h post-XRT. Each experiment was replicated two to three times. Data represent mean ± standard error. Student’s t test was used 
to make comparisons between different groups. *p < 0.05, **p < 0.005, ***p < 0.0005
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radiation resulted in a significant reduction in invasion 
compared to non-irradiated groups (Fig. 5a). We observed 
a similar trend in UW228 cells. When EphB2-siRNA 
transfected cells were exposed to radiation, a significant 
decrease in invasive ability of UW228 cells was observed 
as evident by the decrease in cell index values compared 
to either NS-siRNA or EphB2-siRNA alone (Fig. 5b).
EphB2 knockdown with radiation modulates the 
expression of cell proliferation, invasion, and survival 
proteins
To identify the proteins associated with the effects 
observed following EphB2 knockdown in the presence 
of radiation, Western blot analyses were performed. Our 
data demonstrate a decrease in the levels of PCNA, a 
surrogate marker for proliferation, in both DAOY and 
UW228 cells following combined treatment with EphB2 
knockdown and radiation compared to other groups 
(Fig.  6). The decrease was more prominent in UW228 
cells. In addition, the levels of Bcl-XL, a pro-survival 
marker, were also altered in the combination group 
in DAOY cells (Fig.  6). In UW228 cells, Bcl-XS show a 
slight reduction when the EphB2 knockdown cells were 
exposed to 8  Gy dose of radiation compared to other 
groups (Fig.  6). We also observed changes in the levels 
of proteins such as vimentin that impart invasive char-
acteristics to the cancer cells. The level of vimentin was 
decreased in DAOY cells following EphB2 knockdown 
and radiation compared to other experimental or control 
groups (Fig. 6).
Discussion
Medulloblastoma comprises of one of the most fre-
quently occurring solid malignancies and leading cause 
of cancer related deaths in children. Based on the molec-
ular profiling, medulloblastomas are categorized into 
four principal subgroups: Wnt, Sonic hedgehog (SHH), 
Group 3, and Group 4 [16, 17, 21]. The classification of 
these subgroups is based on the specific signaling path-
ways thought to be dysregulated in their pathogenesis 
and by clinical, histological, and genetic features [17]. 
Currently, treatment strategies for medulloblastoma 
patients are largely influenced by factors such as risk 
stratification and age of the patient. Recent subclassifica-
tion and exploration into the particular pathways and tar-
gets predominantly affected in each of these subgroups 
may allow personalized management of these tumors. In 
the analysis performed on medulloblastoma patients, we 
observed a variable but significant increase in the expres-
sion of EphB2 across the different subgroups compared 
to the normal cerebellum. Growing evidence over the 
past few years have reported aberrant regulation of the 
Eph family of receptors and their cognate ligands in a 
number of human malignancies, including medulloblas-
toma [4–6, 19, 22–24]. In the present study, we investi-
gated, for the first time, the effects of combined EphB2 
knockdown and radiation on cell growth, viability, and 
invasiveness of medulloblastoma cells. Our data show 
that the combined downregulation of EphB2 and radia-
tion exposure decreased clonogenic survival fractions, 
induced G2/M cell cycle arrest, inhibited cell growth and 
viability, and reduced cell invasion. These effects were 
mainly studied in two medulloblastoma cell lines DAOY 
and UW228, that are reportedly associated with the SHH 
subgroup [25, 26].
We documented, for the first time, that EphB2 receptor 
knockdown sensitizes medulloblastoma cells to ionizing 
Fig. 5 EphB2 knockdown in combination with ionizing radiation 
results in decreased cell invasion in medulloblastoma cells. EphB2 
knockdown when combined with radiation significantly decreases 
cell invasion compared to non-irradiated groups in DAOY (a) and 
UW228 (b) cells. Cell invasion was measured in a transwell chamber 
using electrical impedance method. Cell index values represent 
changes in electrical impedance across the membrane separating 
the upper and lower chambers, and show a direct correlation with 
the number of cells that have invaded into the lower chamber. Back-
ground invasion was subtracted to obtain normalized cell index val-
ues. Representative plot is shown in this figure for each individual cell 
line. Each experiment was repeated at least two times. **p < 0.005
Page 9 of 11Bhatia et al. Cancer Cell Int  (2017) 17:41 
radiation. It is consistent with previous reports showing 
that in addition to stimulating tumor growth, develop-
ment, and metastasis, Eph/ephrin family members also 
confer radioresistant characteristics to cancer cells [19, 
27]. Our cell cycle data show an increase in the accumu-
lation of cells in G2/M phase when EphB2-siRNA trans-
fected cells were exposed to an optimal dose of radiation. 
Considering that G2/M phase is one of the most radio-
sensitive phase of the cell cycle, our data is consistent 
with the published literature [28].
Following cell cycle distribution analysis, we also per-
formed cell viability assays demonstrating growth inhibi-
tory effects of EphB2 knockdown when combined with 
radiation. EphB2 knockdown alone did not produce 
any significant changes in cell viability in both DAOY 
and UW228 cells. Our data are consistent with a study 
published by Sikemma and colleagues where they did 
not observe any direct effects on cell proliferation in 
medulloblastoma cell lines following silencing of EphB2 
receptor [5]. However, EphB2 knockdown approach in 
combination with radiation, resulted in a significant 
reduction in viability as observed in both the medullo-
blastoma cell lines. This synergy is further validated in 
clonogenic assay where EphB2 knockdown enhances the 
radiosensitivity of these cells that appears to be partially 
mediated via cell cycle arrest. In line with our functional 
assays, we observed changes in the expression of proteins 
that play a critical role in tumor cell growth, proliferation, 
Fig. 6 EphB2 knockdown with ionizing radiation results in altered expression of cell survival, proliferation, and invasion related proteins in medul-
loblastoma cells. UW228 cells show decreased expression of PCNA, a proliferation marker, in the combined treatment group compared to other 
groups but is reversed to normal baseline levels in the DAOY cell line. Bcl-XL, which is a pro-survival marker, also shows marked reduction in the 
EphB2-siRNA transfected and irradiated group in DAOY cells. Bcl-XS, is slightly reduced in the combination group in UW228 cells. Vimentin, a marker 
that plays a key role in invasion, similarly shows marked reduction when DAOY cells knocked down for the EphB2 receptor were exposed to 8 Gy 
dose of radiation. The analysis was performed 24 h post-XRT for all the markers except for Bcl-XL and Bcl-XS where analysis was performed at 72 h 
post-XRT
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invasion, and cell survival pathways in combined EphB2 
downregulated and irradiated group versus other groups.
Medulloblastoma tumors are characterized by the 
presence of tumor cell populations with high inva-
sive potential, facilitating migration of these cells along 
leptomeningeal surfaces [3]. It has been reported that 
medulloblastoma cells with high migratory phenotype 
exhibit elevated levels of EphB2 receptor [4] that could be 
responsible for increased migration/invasion. Sikemma 
et  al. [5], also demonstrated enhanced effects of ligand-
mediated stimulation of EphB2 receptor on medulloblas-
toma cell invasion, which was further abrogated following 
shRNA mediated silencing of EphB2 receptor. Similar 
results were observed by another group in a GBM model, 
where EphB2 gain-of-function experiments increased 
neurosphere cell migration and invasion [6]. In addition 
to EphB2, other studies in the literature have shown that 
medulloblastoma cells when exposed to radiation exhibit 
enhanced cell invasion [9, 11]. Therefore, in our study, we 
addressed the question whether knockdown of EphB2 
receptor in combination with radiation would decrease 
the pro-invasive characteristics of medulloblastoma cells. 
Our findings show that when DAOY and UW228 cells 
were exposed to radiation, it resulted in decreased cell 
invasion. This is consistent with the findings published by 
Rieken et al. [10]. The key observation in our experiments 
is the significant reduction in invasive potential of medul-
loblastoma cells following combined inhibition of EphB2 
knockdown with radiation compared to other groups. 
This suggests that while EphB2 knockdown by itself may 
not be sufficient to produce desirable result and that 
inhibiting the expression or function of EphB2 could be 
beneficial when used as part of a radiosensitization strat-
egy to reverse the malignant and invasive phenotype.
Conclusions
In conclusion, our data shed light on the efficacy of strat-
egy involving combined EphB2-knockdown with radia-
tion in medulloblastoma. This is evident by alterations in 
clonogenic survival, cell cycle distribution, medulloblas-
toma cell viability, and invasive potential in vitro. Future 
studies are warranted to test the efficacy of combined 
modality described in this study in other pre-clinical 
models. Regardless, our results emphasize the impor-
tance of combined EphB2 downregulation with radiation 
as a potential therapeutic approach to achieve anti-tumo-
rigenic effects in pediatric medulloblastoma.
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